Breaking News from WHO Executive Board Session in Geneva – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“Breaking News from WHO Executive Board Session in Geneva!
Today the World Health Organization Executive Board EB158 approved the decision to recommend adoption of the resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders at the 79th World Health Assembly (WHA) in May 2026!
This decision marks a vital step forward toward the final adoption of this resolution in May, leading to greater health equity for people with Bleeding Disorders.
The World Federation of Hemophilia would like to especially acknowledge the unwavering leadership of the Republic of Armenia, and all co-sponsoring Member States including Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo, and to over 80 patient and medical associations who have joined the WFH’s Global Call for Health Equity for Bleeding Disorders in support of this resolution!
Stay tuned for more updates from the WFH in coming days and weeks on the next steps towards final adoption of the resolution at the 79th World Health Assembly in May 2026.”
Harshal Kale, Regional Program Manager of South Asia and East Asia at World Federation of Hemophilia, shared this post, adding:
“A meaningful step forward as the WHO Executive Board recommends adoption of the Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders (EB158) at the World Health Assembly in May 2026.
Proud to have contributed to regional advocacy efforts securing co-sponsorships from Nepal and Sri Lanka. Grateful to Armenia and all the supporting Member states, patient organisations, and medical associations for driving this global call to action.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins
-
Jun 27, 2026, 14:01Francesca Palandri: Highlighting Innovation in Rare Disease Care at EHA 2026
-
Jun 27, 2026, 13:51Mubariz Ahsan: Trends in Stroke Mortality in Peripheral Artery Disease from CDC WONDER Study
-
Jun 27, 2026, 13:40Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
-
Jun 27, 2026, 13:27Limited-Time Open Access for the EAHAD 2026 Joint Session with ISTH – EAHAD
-
Jun 27, 2026, 13:16Stefano Rivella: Stress Erythropoiesis and the Role of HRG1-Mediated Heme Import
-
Jun 27, 2026, 13:10Yahya Samadi: Luspatercept Shows Promise in Reducing Transfusion Burden in β-Thalassemia